Contemporary prognosis of transient ischemic attack patients:a systematic review and meta-analysis by Najib, Nashwa et al.
 
 
University of Birmingham
Contemporary prognosis of transient ischemic
attack patients
Najib, Nashwa ; Magin, Parker J; Lasserson, Daniel; Quain, Debbie ; Attia, John;
Oldmeadow, Christopher ; Garcia-Esperon, Carlos ; Levi, Christopher R
DOI:
10.1177/1747493018823568
License:
None: All rights reserved
Document Version
Peer reviewed version
Citation for published version (Harvard):
Najib, N, Magin, PJ, Lasserson, D, Quain, D, Attia, J, Oldmeadow, C, Garcia-Esperon, C & Levi, CR 2019,
'Contemporary prognosis of transient ischemic attack patients: a systematic review and meta-analysis',
International Journal of Stroke, vol. 14, no. 5, pp. 460-467. https://doi.org/10.1177/1747493018823568
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 17/01/2019
Najib, N., Magin, P., Lasserson, D., Quain, D., Attia, J., Oldmeadow, C., Garcia-Esperon, C. and Levi, C, Contemporary prognosis of
transient ischemic attack patients: A systematic review and meta-analysis, International Journal of Stroke. Copyright © 2019 World Stroke
Organization. DOI: 10.1177/1747493018823568.
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
 CONTEMPORARY PROGNOSIS OF TRANSIENT ISCHAEMIC ATTACK PATIENTS:  
A SYSTEMATIC REVIEW AND META-ANALYSIS 
 
Nashwa Najib1MBBS, M Phil (Medicine) 
Parker Magin2FRACGP 
Daniel Lasserson3MRCGP, FRCP Edin 
Debbie Quain4BA (Nursing) 
John Attia4,5FRACP, FRCPC 
Christopher Oldmeadow5PhD 
Carlos Garcia-Esperon6MD 
Christopher Levi2,7FRACP 
 
 
1,4School of Public Health and Medicine 
Faculty of Health and Medicine 
University of Newcastle 
Newcastle, Australia 
 
2Conjoint Professor 
Faculty of Health and Medicine 
University of Newcastle 
Newcastle, Australia 
 
1 
 
 3Professor of Ambulatory Care  
Institute of Applied Health Research 
College of Medical and Dental Sciences  
University of Birmingham, UK 
 
5Public Health Stream 
Hunter Medical Research Institute 
Newcastle, Australia 
  
6Acute Stroke Service, John Hunter Hospital 
Newcastle, Australia 
 
 
7Senior Staff Neurologist, John Hunter Hospital 
Newcastle, Australia 
 
 
 
 
  
2 
 
 Address for correspondence: 
Dr Nashwa Najib 
Fax number: +61 2 9756 5755 
Telephone number: +61 475 918 974 
Email address: najib_nashwa@yahoo.com.au 
Faculty of Health and Medicine 
University of Newcastle 
University Drive 
Callaghan, 2308 
Australia 
 
Cover title: CONTEMPORARY PROGNOSIS OF TRANSIENT ISCHAEMIC ATTACK 
PATIENTS - A SYSTEMATIC REVIEW AND META-ANALYSIS 
Key words: Ischaemic Attack, Transient; Prognosis; Meta-analysis; Cerebrovascular 
disorders; Delivery of health care, Neurology. 
Word count: 4200 
Tables: 1 
Table 1: Study specific stroke risk 
Figures: 2 
Figure 1: PRISMA 2009 Flow Diagram 
Figure 2: Cumulative risk of stroke pooled over 40 studies 
  
3 
 
 Abstract 
 
Background 
Transient ischaemic attacks (TIAs) are common and place patients at risk of subsequent 
stroke. The 2007 EXPRESS and SOS-TIA studies, demonstrated the efficacy of rapid 
treatment initiation. We hypothesised that, with these findings having informed subsequent 
TIA management protocols, TIA prognosis in contemporary (2008 and later) patient cohorts 
would be more favourable than in historical cohorts.  
 
Methods 
A systematic review and meta-analysis of cohort studies and RCT placebo-arms of TIA 
(published 2008-2015). The primary outcome was stroke. Secondary outcomes were 
mortality, TIA and myocardial infarction. Studies were excluded if the outcome of TIA 
patients was not reported separately. The systematic review included all studies of TIA. The 
meta-analysis excluded studies of restricted TIA patient types (e.g. only patients with AF). 
The pooled cumulative risks of stroke recurrence were estimated from study-specific 
estimates at 2, 7, 30 and 90 days post-TIA, using a multivariate Bayesian model. 
 
Results 
We included 47 studies in the systematic review and 40 studies in the meta-analysis. In the 
systematic review (191,202 patients), stroke at 2-days was reported in 13/47 (27.7%) of 
studies, at 7-days in 20/47 (42.6%), at 30-days in 12/47 (25.5%) and at 90-days in 33/47 
(70.2%). Studies included in the meta-analysis recruited 68,563 patients. The cumulative risk 
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 of stroke was 1.2% (95% Credible Interval (CI) 0.6-2.2), 3.4% (95% CI 2.0-5.5), 5.0% (95% 
CI 2.9-8.9) and 7.4% (95% CI 4.3-12.4) at 2, 7, 30 and 90 days post-TIA, respectively. 
 
Conclusion 
In contemporary settings, TIA prognosis is more favourable than reported in historical 
cohorts where a meta-analysis suggests stroke risk of 3.1% at 2-days.  
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 Text 
 
Introduction 
 
Transient ischaemic attacks (TIAs) are common and place patients at risk of subsequent 
stroke.(1) Given the considerable potential for mortality and serious morbidity related to 
stroke, the risk of stroke following TIA is a major health issue. In contemporary practice, 
with emerging diagnostic techniques and with revised guidelines incorporating evidence for 
rapid management policies and use of risk stratification strategies, TIA can be diagnosed and 
managed early. Landmark studies (EXPRESS and SOS-TIA)(1, 2) demonstrated that urgent 
evaluation and commencement of therapy markedly reduces the risk of stroke. With 
implementation of these findings in clinical practice, it may be expected that TIA prognosis 
in patients engaging with contemporary health care systems would be more favourable than 
in historical cohorts. We sought to test this hypothesis.  
 
Methods 
We conducted a systematic review of prospective and retrospective cohort studies (hospital-
based and community-based cohorts) of TIA, plus placebo arms of Randomised Controlled 
Trials. We defined contemporary practice as practice reported in studies published in the 
post-EXPRESS /SOS-TIA (post 2007) era. Thus, we included studies published from 2008 to 
2015. The outcomes of interest were stroke, recurrent TIA, myocardial infarction and 
mortality.  
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 Search strategy and screening process 
The search was conducted using the electronic databases Ovid Medline, Cochrane Library 
and Embase. Search limits used were English language, human and 2008-current. The search 
terms used were: [TIA (OR) ischaemic attack, transient (OR) amaurosis fugax] AND 
[outcome (OR) prognosis (OR) follow-up (OR) cohort (OR) randomised control trial (OR) 
risk (OR) natural history].  
The last database search was conducted on 2nd June 2015. 
 
Duplicate results of the search were removed and the abstracts were screened and assessed 
for eligibility. Following screening of abstracts, full-text copies of potentially eligible papers 
were retrieved and assessed for eligibility. The abstracts, methods and outcomes for each 
study were assessed for eligibility separately by two researchers (NN and PM) and any cases 
of disagreement were adjudicated by a third researcher (CL).  
Reference studies of included papers were searched for relevant studies. Papers published 
prior to 2008 were excluded. While acknowledging that papers published later than 2007 may 
still include patients recruited prior to 2007, this provided an identifiable marker of (post-
EXPRESS/SOS-TIA) contemporary TIA practice. 
Inclusion criteria Prospective and retrospective cohort studies (hospital-based and 
community-based cohorts) of TIA were included. In addition to this, placebo-arms of 
randomised control trials were also included. The study factor was TIA and so studies of 
stroke and TIA were included only if TIA was reported separately. The primary outcome 
factor was stroke and secondary outcome factors were recurrent TIA, myocardial infarction 
and death. Studies reporting these outcomes were included. We included in the systematic 
7 
 
 review all studies of TIA even if the entry criteria for the studies were restricted (eg. only 
patients with AF). However, we restricted our meta-analysis to studies with no restriction on 
the type of TIA patients.  
Exclusion criteria Studies with outcomes only at time-points less than 48 hours post-TIA 
were not included in the systematic review. We excluded studies of both stroke and TIA, if 
the outcome of TIA patients were not reported separately.  
For the meta-analysis, studies which included (on the basis of study population selection) 
only higher-risk or only lower-risk patient populations were excluded. These excluded studies 
were: those which defined TIA according to the tissue-based definition rather than the 
traditional World Health Organisation (WHO) time-based definition, studies which excluded 
AF patients, studies which included only patients undergoing CEA and studies which had a 
restricted patient age group.  
TIA definition: The definition of TIA was by each individual study (either standard WHO 
definition or tissue-based definition). 
Outcome definitions: The primary outcome of interest was stroke and we accepted each 
study’s stroke definition. Similarly, we accepted each study’s definition of secondary 
outcomes of myocardial infarction and death.  
The meta-analysis was performed only with stroke as the outcome factor. 
 
 
8 
 
 Data extraction 
The PRISMA 2009 criteria were followed. In studies including patients with both TIA and 
stroke, with the outcome for TIA patients not reported separately, the corresponding author 
was contacted and specific TIA data was requested.  
Extracted information from each article included: title, author, publication year, journal, 
period of data collection, source of TIA diagnosis (eg. ED physician, neurologist), definition 
of TIA (WHO time-based or tissue-based definition), country/countries where the study was 
conducted, study population (eg. ED, hospital in-patient), study participant limitations (eg. 
gender), clinical limitations (eg. carotid stenosis, AF), number of TIA participants at baseline, 
number of TIA participants analysed, study outcomes (in addition to stroke), method of 
outcome ascertainment, type of study (prospective/retrospective cohort, RCT), duration of 
follow-up and results (stroke, mortality, TIA and MI). Data extraction was independently 
performed by two researchers (NN, PM and CE). Any cases of disagreement were 
adjudicated by a third researcher (CL). 
 
Statistical Analysis 
Meta-analysis: We conducted a meta-analysis of 40 studies (33 prospective studies, 7 
retrospective studies) with outcome factor stroke. The time-points of interest for cumulative 
risk of stroke recurrence are at 2, 7, 30 and 90 days post-TIA. We aimed to estimate the 
pooled cumulative risk of stroke recurrence at each time point. 
A standard meta-analysis of the risk at each time point is problematic since the same studies 
do not contribute data at each possible time-point; as such, estimates of the pooled 
cumulative risk at each time-point are not guaranteed to be non-decreasing since the within-
study correlation of estimates are ignored. We utilise a model for the multivariate (joint) 
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 analysis of all studies at every available time point. In this approach, information is borrowed 
from studies that contribute to multiple time-points, improving the precision of the estimates, 
and the cumulative probabilities of stroke are explicitly constrained to be non-decreasing. We 
have utilised the Bayesian model presented in Jackson et al.(3) Briefly, the probability of 
stroke at each study for each period is modelled on the log-odds scale to be the sum of the 
unconditional log-odds of stroke at each time point (averaged across sites) and  a study 
specific random effect (to model between study heterogeneity), assumed to follow a 
multivariate normal distribution. The unconditional probability of stroke at each time point 
(averaged across sites) is the parameter of interest, reflecting the pooled cumulative risk at 
each time-point. To complete the Bayesian model, uninformative prior distributions were 
placed on all model parameters; a Wishart prior was used for the covariance matrix of the 
random effect, and normal distributions (zero mean and variance of 1000) were used for the 
four time-specific unconditional log-odds parameters. 
Bayesian inference was implemented via Markov Chain Monte Carlo simulation using the 
WinBUGS software(4) where we took 500,000 simulations from the posteriors joint 
distribution, allowing for a burn-in period of 50,000 simulations. Pooled cumulative stroke 
risks are summarised from the posterior distribution as the mean with 95% credible intervals 
given as the 2.5 and 97.5 percentiles. Convergence was assessed through inspecting trace 
plots of the MCMC simulated values, and running two MCMC chains to assess convergence 
using the Gelman-Rubin diagnostics. Data manipulation, summarizing and graphing was 
performed using R V3.3 software.(5) 
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 Results 
Study selection 
 
Databases searching yielded a total of 4304 publications. After excluding duplicate records 
and screening, 130 full-text articles were retrieved and assessed for eligibility. Eighty-three of 
these studies were excluded. Five RCT placebo arms met our inclusion criteria but were not 
included as the authors did not respond to our request for additional data. The remaining 
forty-seven studies met the inclusion criteria and were included in the systematic review. We 
included forty studies in the meta-analysis.  
 
Systematic Review 
 
Characteristics of studies/data: Forty-seven studies (N=191,202 patients) were included in the 
systematic review. The study characteristics are summarised in supplementary table 1. In all 
47 studies, the patients had a TIA as an index event at baseline.  
Diagnosis: The diagnostic criteria for TIA were the time-based WHO definition (32/47 
(68.1%) of the studies) or tissue-based definition (3/47 (6.4%) of the studies). In 12/47 
(25.5%) of studies, TIA definition was not reported. We assumed a standard WHO time-
based definition in these studies. In 25/47 (53.2%) of studies, the TIA diagnosis was made by 
a neurologist. ED physicians and stroke physicians made the diagnosis in 6/47 (12.8%) and 
3/47 (6.4%) of studies, respectively. In 1/47 (2.1%) of studies, a physician made the 
diagnosis. Vascular neurologists made the diagnosis in 2/47 (4.3%) of studies. In 10/47 
(21.3%) of studies it was not reported who made the diagnosis.  
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 Study population: The admission criteria and patient population were also different among 
studies. In 19/47 (40.4%) of studies, the study population were non- selected ED care/ all 
comers. Hospital in- patient admission with a clear admission policy (study participant 
limitations such as age, gender, MRI/MRA on admission, carotid stenosis and admission 
within either 24 hours or 48 hours of symptom onset) accounted for 8/47 (17%) of studies, 
whereas 9/47 (19.1%) of studies included in-patient hospital admissions but without a clear 
admission policy or with admission policy not stated. In 2/47 (4.3%) of the studies, the 
patients referred to a stroke clinic were included in the study and 2/47 (4.3%) of the studies 
had patients from a TIA clinic. In 2/47 (4.3%) of studies, included patients from ED (attended 
by neurologist) and there were 2/47 (4.3%) community studies. In 2/47 (4.3%) of the studies, 
the location of the study population was not reported and in 1/47 (2.1%) of the studies had 
unclear study population. 
Outcome reporting: Stroke at 2-days was reported in 13/47 (27.7%) of studies, at 7-days in 
20/47 (42.6%), at 30- days in 12/47 (25.5%) and at 90-days in 33/47 (70.2%). 
TIA was reported in 15/47 (31.9%) of studies, mortality in 19/47 (40.4%) and MI in 9/47 
(19.1%). Unlike for stroke, for TIA, MI and mortality reporting was often not at consistent 
time points (such as at 2-days, 7-days, 30-days and 90-days), making calculation of summary 
statistics problematic. The follow-up period varied between studies (from 72 hours to 13.8 
years) and varied even within studies for different outcomes (refer to supplementary table 1 
for individual studies).  
 
Meta-Analysis 
The 40 studies included 68,563 patients. The MCMC chains from the Bayesian multivariate 
meta-analysis model appeared to converge to stable distributions after excluding the first 
12 
 
 50,000 simulations, summaries of the posterior distributions for cumulative risks at each 
time-point are provided in Table 1. The study specific stroke risks at each time point are 
plotted together with estimates of the pooled risks in Figure 2, where each  dot represents an 
individual study. 
 
Discussion 
Summary of main findings 
The systematic review displayed variability in definition of TIA and clinical status of a 
person making the diagnosis of TIA. A few studies had markedly restricted study 
populations. While there were differences in study populations’ location of care and service 
model between studies, the participants were almost all managed in secondary care rather 
than primary care.  
The meta-analysis of 40 studies showed a cumulative risk of stroke of 1.2%, 
95%CrI[0.006,0.022]at 2 days, 3.4%, 95%CrI[0.02,0.055] at 7 days, 5.0%, 
95%CrI[0.029,0.082] at 30 days and 7.4%, 95%CrI[0.043,0.124] at 90 days. 
 
Comparison with previous studies(pre-EXPRESS/SOS-TIA) 
The early Oxfordshire study (1981-1986) reported stroke risk of 8.6% at 7-days and 12.0% at 
30-days post-TIA.(6) The Greater Cincinnati/Northern Kentucky Stroke Study (1993-1994) 
reported stroke risk of 14.6% after TIA.(7) The California study (1997-1998), reported 90-
days stroke risk of 10.5%.(8) A Canadian study (1999-2000) reported 90 days stroke risk as 
9.5%.(9) In Northern Portugal (1998-2000), the 7-day stroke risk was found to be 12.8%.(10) 
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 A small number of pre-EXPRESS studies reported stroke risk equivalent to, or less than in, 
our meta-analysis. An ED based study in Canada (in 2000) reported 30-day stroke risk of 
5%.(11) In another study conducted in France (2003-2005), of patients admitted to the stroke 
unit, the stroke risk at 1 week and 3 months was found to be 2.5%  and 3.5%, 
respectively.(12) 
A systematic review and meta-analysis published in 2007, however found stroke risk of 3.1% 
at 2-days (compared to 1.2% in our meta-analysis) and 5.2% at 7-days (compared to 3.4% in 
our meta-analysis) and lowest risks were seen among patients treated in specialist stroke 
services.(13) 
Thus, recurrent stroke-risk in these ‘pre-EXPRESS/pre-SOS-TIA’ studies was generally 
greater than (often considerably greater than) than the stroke-risk in our meta-analysis.  
Stroke risks in our meta-analysis were greater than in SOS-TIA and in ‘phase 2’ of 
EXPRESS. In SOS-TIA (2003-2005), 90-day stroke risk was 1.24%(2) In EXPRESS (2004-
2007), the 90- day stroke risk decreased  from 10.3% in phase 1 to 2.1% in phase 2.(1) Stroke 
risk in our meta-analysis was also greater than in a large study reported subsequent to our 
review and meta-analysis (see below).(14) 
Interpretation of the findings 
We have found that, compared to findings in pre-EXPRESS historical cohorts, our meta-
analysis of studies in more contemporary health settings reported lower rates of stroke 
following a TIA. 
In ‘optimal’ contemporary practice, Amarenco et al’s recent multi-site study (2009-2011) 
published in 2016 (subsequent to our review) found that stroke rates following a TIA or 
minor stroke at 2, 7, 30 and 90 days were 1.5%, 2.1%, 2.8% and 3.7%, respectively.(14) That 
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 is, lower rates than in our meta-analysis. This study was conducted (like EXPRESS and SOS-
TIA) in highly specialised settings where urgent evaluation and management of TIA was 
implemented via protocols in accordance with evidence-based best practice care.  
Thus, we have demonstrated a gradient of highest stroke risk post-TIA in findings from 
‘historical’ cohorts (highest risk), to the findings of ‘post-EXPRESS’ cohorts included in our 
meta-analysis, to the findings of a ‘contemporary best-practice’ cohort (lowest risk). 
The defining characteristic of clinical practice (reflected in evidence-based clinical 
guidelines) (15-17) contemporaneous with this gradient in findings is decreasing time from 
incident event to initiation of management. Treatment modalities were largely unchanged. 
 
Strengths and limitations 
Strengths:  
A strength of this systematic review and meta-analysis is the large number of studies from 
across a wide range of (secondary care) health care settings from around the world. In the 47 
studies included in the systematic review, there were 191,202 patients, with 68,563 patients 
included in the meta-analysis. 
Limitations: 
An important limitation is a time lag in introduction of system change in TIA care, data 
collection and publication. Our sample population of studies included some patients who 
received treatment before the EXPRESS/S0S-TIA studies’ publication (i.e. pre-2007). This 
together with different patient population and different health systems’ approaches (not 
always informed by EXPRESS/SOS-TIA findings), makes our sample population highly 
heterogeneous. Hence, an appreciable proportion of patients in our systematic review and 
meta-analysis would not have received what is considered optimal care post-EXPRESS/SOS-
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 TIA. This, however, would have biased our findings towards the null, i.e. less difference in 
stroke-rates between historical and post-EXPESS studies. Our results remain robust from this 
viewpoint.  
Secondly, there is a difference in ascertainment of study factor (TIA) in different studies. The 
case ascertainment method varied across studies. Most studies diagnosed TIA as per the time-
based WHO definition while some studies followed the tissue-based definition. Studies 
explicitly employing tissue-based definition of TIA were however, excluded from our meta-
analysis. 
Additionally, there was heterogeneity in clinicians making the diagnosis of TIA, ranging 
from stroke physicians to ED physicians to ED residents.(18) Given the frequent difficulty of 
TIA diagnosis, there is potential for differences in diagnostic accuracy between included 
studies.(19) 
 
Implications for practice and policy 
A consideration of our findings in the context of previous literature and changes in evidence-
based clinical guidelines suggests that the poorer prognosis in historical population contrasted 
with findings of more contemporary populations may be due to TIA patients being treated 
less intensely in historical cohorts. Furthermore, the results of the study conducted in expert 
tertiary stroke care centres and published in 2016,(14) suggest that with closer adherence to 
contemporary best practice, even better prognosis of TIA can be achieved. This difference 
suggests that clinical expertise and/or systems of care continue to be important factors in TIA 
outcomes in contemporary practice. 
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 Implementation of best evidence TIA management requires organised systems of care. 
Although many hospitals in many countries have stroke units and acute neurovascular clinics, 
equipped with modern diagnostic facilities and specialist staff to provide optimal care, delays 
in seeking medical help and delays in management will likely be continuing to have a 
negative impact on TIA outcomes even in such systems.(20) It is important that patients 
understand the symptoms of TIA and the health practices make a correct diagnosis and 
initiate treatment urgently. 
 
Implications for further research 
The processes of care and outcomes of TIA patients can be improved by having optimal 
infrastructure. In many settings, such a highly specialised care system, with specialised 
personnel and availability of advanced technologies outside of a research setting, is not 
feasible.(21) 
Prehospital care after a TIA plays an important role in primary health care settings. Managing 
TIA patients effectively in primary health care settings is of prime importance, as most of the 
patients seek initial help from their primary care physicians. General practitioners (GPs) have 
a role in managing TIA.(21) System delays however can result in many patients presenting to 
GPs not receiving appropriate care within guideline-benchmarked timeframes.(21, 22) Future 
research could evaluate models of integrated GP-specialist care utilizing, for example, 
telemedicine (which has proven effective in acute stroke care). 
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 Conclusion 
We hypothesised that the prognosis of TIA patients in studies reported in the years post-2007 
will be improved compared to studies reported prior to 2008. We found that the prognosis of 
TIA patients is more favourable in the modern health care settings. This may reflect 
improvements in service models for TIA patients’ care; with research evidence being 
translated promptly (though not always completely) into clinical practice.  
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 Figure legends 
 
Table 1: Study specific stroke risk 
Figure 1: PRISMA 2009 Flow Diagram 
Figure 2: Cumulative risk of stroke pooled over 40 studies 
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 Table 1: Study specific stroke risk 
 
Time point Cumulative risk of stroke 95% credible 
interval 
I2 
2 days 0.012 0.006,0.022 0.87 
7 days 0.034 0.02,0.055 0.93 
30days 0.05 0.029,0.082 0.95 
90 days 0.074 0.043,0.124 0.96 
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 Figure 1: PRISMA 2009 Flow Diagram 
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Number of records screened 577 
Number of records excluded-447 
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Study outcomes other than stroke, mortality, TIA 
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Express studies (4) 
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Not cohort or RCT (17) 
Diagnostic study not prognostic study (1) 
Overlap/Duplicate study (3) 
Primary outcome not stroke (10) 
case-series/case –control study (1) 
Protocol paper (1) 
Stroke outcome not time defined (7) 
Data from multiple previous studies (1) 
TIA less than 24hrs (1) 
TIA  not index event (1) 
TIA not reported (1) 
Published prior 2008(7) 
 
 
 
 
 
Number of records excluded on the basis of title and 
duplicates-3727 
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Number of studies included in meta- analysis-40 
Number of studies excluded from meta-analysis-7 
Reasons for exclusion: 
TIA defined by tissue-based definition not time-based 
definition(3) 
Study excluded patients who had AF (2) 
Study included only patients undergoing CEA (1) 
Restricted age group (1) 
 
 
*May not add to 83 because of more than one reason of exclusion 
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 Figure 2: Cumulative risk of stroke pooled over 40 studies 
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